Similarly, deleting CCL2, which encodes monocyte chemoattractant protein-1, attenuated renal tubule cell damage [16], and suppressed development of diabetic nephropathy in streptozotocin (STZ)-treated mice [17]. Here, CCL2 is linked to diabetic kidney disease.